Virtual Cell Models and Lab-in-the-Loop Strategy
An executive analysis of the shift from static biological mapping to predictive virtual cell models. This brief explores the commercial viability of lab-in-the-loop systems, the critical role of high-scale perturbation data, and the strategic pivot from pure AI platforms to integrated data generation businesses.